Song C F, Li H, Tian B, Chen S, Miao J B, Fu Y L, You B, Hu B
Department of Thoracic Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Zhonghua Wai Ke Za Zhi. 2017 Sep 1;55(9):661-666. doi: 10.3760/cma.j.issn.0529-5815.2017.09.005.
To investigate the current status of prevention and treatment of venous thromboembolism (VTE) after thoracic surgery in China. Chinese thoracic surgeons were investigated by the online questionnaire which was based on the Chinese version of International VTE questionnaire added with 6 extra questions with Chinese characteristics. A total of 1 150 valid questionnaires were retrieved, accounting for about 20% of all the Chinese thoracic surgeons. The surgeons participating in this survey came from all over the country, most of whom were experienced professionals with high academic titles.For lung cancer patients, 66.96% (770/1 150) of the surgeons suggested that VTE prophylaxis should start 1 day after lung cancer resection, and 64.61% (743/1 150) of the surgeons suggested extending after discharge. For esophagestomy patients, and 48.35% (514/1 063) of the surgeons suggested that there was no need for patients to extend VTE prophylaxis after discharge. More than half of the surgeons participating in this survey made decision of the method and duration of VTE prophylaxis after lung cancer resection (53.91% (620/1 150)) or esophagectomy (52.49% (558/1 063)) depending on the clinical experience.Low molecular weight heparin was the common choice of most surgeons in VTE prophylaxis. More than half of the surgeons thought that previous history of VTE, advanced age, complicated with thrombophilia, obesity (body mass index>30 kg/m), duration of surgery longer than 6 hours and family history of VTE were key risk factors of the occurrence of postoperative VTE. The results of this survey are highly credible and are a good reflection of the current status of VTE prevention and treatment after thoracic surgery in China. This survey will play an important role in promoting VTE prevention and treatment in Chinese thoracic surgery department, it will also provide data support for government setting new policies, hospital construction of VTE prevention and control as well as raising physicians' awareness.
调查中国胸外科手术后静脉血栓栓塞症（VTE）的防治现状。采用在线问卷对中国胸外科医生进行调查，问卷基于国际VTE问卷中文版，并额外增加了6个具有中国特色的问题。共收回有效问卷1150份，约占中国胸外科医生总数的20%。参与本次调查的外科医生来自全国各地，其中大多数是经验丰富、职称较高的专业人员。对于肺癌患者，66.96%（770/1150）的外科医生建议VTE预防应在肺癌切除术后1天开始，64.61%（743/1150）的外科医生建议出院后继续。对于食管癌患者，48.35%（514/1063）的外科医生认为患者出院后无需继续VTE预防。参与本次调查的外科医生中，超过半数在肺癌切除术后（53.91%（620/1150））或食管癌切除术后（52.49%（558/1063））根据临床经验决定VTE预防的方法和持续时间。低分子肝素是大多数外科医生在VTE预防中的常用选择。超过半数的外科医生认为VTE既往史、高龄、合并血栓形成倾向、肥胖（体重指数>30 kg/m²）、手术时间超过6小时以及VTE家族史是术后VTE发生的关键危险因素。本次调查结果可信度高，很好地反映了中国胸外科手术后VTE防治的现状。本次调查将对推动中国胸外科VTE防治工作发挥重要作用，也将为政府制定新政策、医院开展VTE防控建设以及提高医生认识提供数据支持。
